X
    X
    X
    X

    Novartis Series B Stock Financing

    In April 2011, our lawyers represented Novartis Bioventures in the $13,945,340 Series B Stock Financing and second closing of a Series B Investment in Akebia Therapeutics, Inc. Akebia Therapeutics, Inc., based in Cincinnati, Ohio, is a biopharmaceutical company that engages in the discovery and development of small molecules for the treatment of anemia and vascular disorders. Akebia Therapeutics, Inc. was founded in 2007. Novartis Bioventures, is a venture fund based in Cambridge, Massachusetts.

    Disclaimer

    Please understand that your communications with Locke Lord LLP through this website do not constitute or create an attorney-client relationship with Locke Lord LLP. Any information you send to Locke Lord LLP through this website is on a non-confidential and non-privileged basis. Therefore, do not send or include any information in your email that you consider to be confidential or privileged.